Users Online: 6411 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size


Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

 Table of Contents  
Year : 2011  |  Volume : 55  |  Issue : 3  |  Page : 155-160  

Tobacco use: A major risk factor for non communicable diseases in South-East Asia region

1 Non Communicable Diseases and Social Determinants of Health Cluster, WHO India Country Office, New Delhi, India
2 Department of Sustainable Development and Environment, WHO South East Asia Regional Office, New Delhi, India
3 WHO Representative of India, India

Date of Web Publication16-Nov-2011

Correspondence Address:
J S Thakur
Cluster Focal Point, Non Communicable Diseases and Social Determinants of Health, WHO India Country Office, New Delhi - 110 011
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0019-557X.89943

Rights and Permissions

Tobacco use is a serious public health problem in the South East Asia Region where use of both smoking and smokeless form of tobacco is widely prevalent. The region has almost one quarter of the global population and about one quarter of all smokers in the world. Smoking among men is high in the Region and women usually take to chewing tobacco. The prevalence across countries varies significantly with smoking among adult men ranges from 24.3% (India) to 63.1% (Indonesia) and among adult women from 0.4% (Sri Lanka) to 15% (Myanmar and Nepal). The prevalence of smokeless tobacco use among men varies from 1.3% (Thailand) to 31.8% (Myanmar), while for women it is from 4.6% (Nepal) to 27.9% (Bangladesh). About 55% of total deaths are due to Non communicable diseases (NCDs) with 53.4% among females with highest in Maldives (79.4%) and low in Timor-Leste (34.4%). Premature mortality due to NCDs in young age is high in the region with 60.7% deaths in Timor Leste and 60.6% deaths in Bangladesh occurring below the age of 70 years. Age standardized death rate per 100,000 populations due to NCDs ranges from 793 (Bhutan) and 612 (Maldives) among males and 654 (Bhutan) and 461 (Sri Lanka) among females respectively. Out of 5.1 millions tobacco attributable deaths in the world, more than 1 million are in South East Asia Region (SEAR) countries. Reducing tobacco use is one of the best buys along with harmful use of alcohol, salt reduction and promotion of physical activity for preventing NCDs. Integrating tobacco control with broader population services in the health system framework is crucial to achieve control of NCDs and sustain development in SEAR countries.

Keywords: Non communicable diseases, Risk factors, Tobacco attributable mortality, Tobacco control

How to cite this article:
Thakur J S, Garg R, Narain J P, Menabde N. Tobacco use: A major risk factor for non communicable diseases in South-East Asia region. Indian J Public Health 2011;55:155-60

How to cite this URL:
Thakur J S, Garg R, Narain J P, Menabde N. Tobacco use: A major risk factor for non communicable diseases in South-East Asia region. Indian J Public Health [serial online] 2011 [cited 2023 Mar 26];55:155-60. Available from:

   Introduction Top

Tobacco use is an important modifiable risk factor common to major non communicable diseases (NCDs)-cancer, cardiovascular diseases, chronic respiratory diseases and diabetes, causing 1 in 6 of all NCD deaths. Almost 6 million people die from tobacco use each year, both from direct tobacco use and second hand smoke. By 2020, this number will increase to 7.5 million, accounting for 10 million deaths. [1] Data from several studies indicate that tobacco smokers have 2-3 fold higher relative risk of coronary heart disease (CHD), 1.5 times for stroke, 1.4 times for chronic obstructive pulmonary disease (COPD) and 12 fold risks for lung cancer. These risks have an age-gradient with higher relative risk (5-6 times) in the younger age groups, and are similar for men and women. [2],[3] and decreases rapidly after quitting smoking. [4] Even exposure to second-hand smoke (SHS) increases the risk of developing and progression of atherosclerosis. [5] Tobacco smoke has synergistic action with other risk factors.

A large multi-centric study in India had concluded that smoking imposes a higher risk for COPD among men, while SHS exposure was an important risk factor among women who were not significantly exposed to solid fuel combustion. SHS exposure was in fact a stronger risk factor than solid fuel combustion. [6] Additionally SHS exposure during childhood is a significant risk factor for the development of asthma in adults. Combined SHS exposure from parents during childhood and spouse during adulthood is associated with maximum risk. [7] The oral use of smokeless tobacco is widely prevalent in South East Asia Region (SEAR) countries; the different methods of consumption include chewing, sucking and applying tobacco preparations to the teeth and gums. Tobacco chewing in its various forms is directly responsible for cancers of the oral cavity, esophagus, pharynx, cervix and penis. Tobacco being key risk factors for NCDs, this paper highlights the crucial role of tobacco control, its impact on development and potential for integration along with other best buys for prevention and control of NCDs in SEAR countries. Information on tobacco use and exposure has been collected from published papers, reports, WHO STEP wise surveys, and reports of Global Youth Tobacco Survey, Global Adult Tobacco Survey and recently released report on Profile of implementation of WHO Framework convention on Tobacco Control in South Asia Region. [8]

   Prevalence of tobacco in SEAR Top

Comparable figures of smoking among men and women in the countries of SEAR region are shown in [Table 1]. Smoking among men is high in the region and the prevalence among countries varies significantly. Smoking among adult men ranges from 24.3% (India) to 63% (Indonesia) and among adult women from 0.4% (Sri Lanka) to 15% (Nepal). The low level of prevalence of smoking among women is because of the fact that smoking by women is not acceptable by most of the communities. In contrast to smoking, the use of smokeless tobacco is quite popular among women. The prevalence of smokeless tobacco use among men varies from 1.3% (Thailand) to 31.8% (Myanmar), while for women it is from 4.6% (Nepal) to 27.9% (Bangladesh). Finding from Global Youth Tobacco Survey (GYTS) show that the current use of any form of tobacco among student aged 13-15 years ranges from 8.5% (Maldives) to 54.5% (Timor-Leste) among boys and from 3.4% (Maldives) to 29.8% (Timor-Leste) among girls. Tobacco accounts for 6% of all female and 12% of all male deaths in the world. Smoking is estimated to cause about 71% of lung cancers, 42% of chronic respiratory diseases and nearly 10% of cardiovascular diseases. [1]
Table 1: Prevalence of tobacco use by sex, in select Member States of the Region

Click here to view

   Burden of NCDs and tobacco attributable mortality Top

The distribution of NCD deaths in SEAR countries due to NCD is shown in [Table 2]. About 55% of total deaths are due to NCDs with 53.4% among females. There is a lot of variation in NCD deaths of the total deaths in region with highest in Maldives (79.4%) and low in Timor-Leste (34.4%). Premature mortality due to NCDs in young age is high in the region with 34% of the deaths due to NCDs occurring below the age of 60 years, and 48% below the age of 70 years. Country-wise variations indicate 60.7% deaths in Timor Leste and 60.6% deaths in Bangladesh in this age group [Table 3]. Age standardized death rate per 100,000 populations due to NCDs varies significantly in the region. It ranges from 793 (Bhutan) and 612 (Maldives) among males and 654 (Bhutan) and 461(Sri Lanka) respectively among females per 100,000 population. The age standardized deaths rates due to cardiovascular diseases and diabetes are high among males and females in the SEAR countries with 465 among males in Bhutan and 387 among females in Bangladesh per 100,000 populations respectively. In 2008, 1.1 million people die of cancer in the Region. Among the 569,000 cancer deaths among males, the commonest site was lung (17%), followed by mouth and oropharynx (15%), and liver (7.5%).
Table 2: Sex wise distribution of non communicable disease deaths out of total deaths in South East Asia Region countries, 2008

Click here to view
Table 3: Age standardized death rates due to non communicable diseases in SEAR Countries

Click here to view

Out of 5.1 millons tobacco attributable deaths in world, more than 1 million are in SEAR countries. Population attributable fraction due to tobacco is 8.7% of deaths as compared to 3.8% in the world. Death rate due to NCDs attributable to tobacco per 100,000 populations is 190 among males and 12 among females respectively in India. Similarly 16% of NCD deaths are attributable to tobacco among males and 1% among females in India (SEARO unpublished data). However, data about NCD deaths attributable to tobacco is not available for all countries in the region.

   Tobacco as a developmental issue Top

Tobacco use impedes economic and social development. One half of the smoker die from their tobacco use, and half of the deaths occur in economically productive years from 35 to 69 years. In low income countries, purchase of tobacco can divert up to 10% of the total household expenditure. [9] A recent systematic review conducted by WHO to find out the link between tobacco and poverty has shown an inverse relationship between income level and tobacco use prevalence, and its related consequences. [10] In analyzed population, low income people smoke more than higher income people (OR 1.48, 95% CI 1.38-1.59). This result is seen in each of the evaluated WHO regions including SEARO (OR 1.18, 95% CI 0.75-1.85) except for WPRO. A study of impact of tobacco related diseases in Bangladesh shows that 41% of eight selected tobacco related diseases (IHD, lung cancer, stroke, oral cancer, cancer of larynx, COPD, Pulmonary tuberculosis and Buerger's disease) were attributable to tobacco and annual cost of tobacco related illness was 50.9 billion taka; 5.8 billion taka for second hand smoke. [11] Member countries of the region have demonstrated that tobacco users from low income families spend up to 40% of their income on smoking at the cost of their basic needs which, in turn, thrust them deeper into a vicious cycle of poverty. [8] Progress towards achievement of MDGs will also be hampered in the region if tobacco control measures are not effectively implemented in SEAR countries.

   Evidence of association of Tobacco with NCDs Top

Ever since the work by Doll and colleagues in the 1950, there has been substantial interest in measuring the impact of tobacco use on health outcome at the population level. [12],[13] Tobacco causes at least 16 different types of cancer. It is most closely associated with lung cancer; the world's leading cause of cancer deaths, accounting for nearly one in five cancer deaths. [14] Tobacco use is known to cause several cancers of the throat and oral cavity, as well as cancer in diverse sites, such as the bladder, kidney, stomach and uterine cervix. Smokeless tobacco causes oral and other cancers, hypertension and heart disease. Cardiovascular disease is the leading cause of death in the world. [14] Smoking increases the risk of heart disease and stroke by two to four times. Smoking causes chronic lung diseases that can be severely disabling or fatal, increasing the risk of death 12 times. Smoking is an independent risk factor for diabetes, and it has been estimated that 12% of diabetes incidence in the United States is attributable to smoking. [14] Diabetics who smoke have an increased risk of death, and of complications associated with diabetes, such as amputations and problems with vision. There is significant tobacco related morbidity and mortality in the SEAR countries. About 1.2 million deaths occur in the region every year. [8] A study in 2010 estimated that smoking would lead to around 930 000 adult deaths in India alone in that year. [15]

   Best buys for Preventing NCDs Top

Reducing tobacco use is one of the best buys for preventing NCDs along with reducing harmful use of alcohol, promotion of healthy diet and physical activity [Table 4]. A best buy is an intervention that is not only highly cost effective but also cheap, feasible and culturally acceptable to implement. [1] Tobacco control interventions has high impact on burden of non communicable diseases, high feasibility and should be directed towards whole population and will be benefit for the poor, and reduce inequities. [16] The priority in SEAR countries should be immediate action to achieve global goal by 2040 of a world essentially free from tobacco where less than 5% of the population use tobacco. [16]
Table 4: Interventions identifi ed as 'Best Buys' to tackle non-communicable disease risk factors

Click here to view

Full implementation of four of the Framework Convention on Tobacco Control strategies (Increasing tax on tobacco products to reduce prevalence, enforcement of smoke free workplaces, requirement of FCTC compliant packaging and labelling of tobacco products combined with public awareness campaigns about the health risk of smoking; and a comprehensive ban on tobacco advertising, promotion and sponsorship) would avert 5.5 million deaths over 10 year in 23 low income and middle income countries with a high burden of NCDs. [17] These are each considered best buys in reducing tobacco use and preventing NCDs. [1] FCTC implementation will have immediate health and economic benefit because reduction in exposure to tobacco smoke, both direct and second hand, will reduce the burden of cardiovascular diseases within one year and thus health expenditure. [18] Smoke free laws are expected to reduce lung cancers, illness from heart diseases and respiratory symptoms. [12] Between 1988 and 2004, a period during which the state of California implemented smoke-free legislation, rates of lung and bronchial cancer declined four times faster in California than in the rest of the United States, although at least some of the decrease may result from the sharper decline in smoking prevalence experienced in California compared with rest of the country that began in the early1980s. [19] Civic bodies of some of the cities of SEAR countries are also working for smoke free cities. Chandigarh, in the Northern part of India, became smoke free in 2007 by active participation of civil society, academic institutions and local administration. [20]

INTERHEART study, a case-control study, done in 52 countries involving more than 12000 cases and 14000 controls estimated the population attributable risk associated with various simple risk factors for incident myocardial infarction in several regions of the world. [21] Among South Asians countries (comprising of Bangladesh, Nepal, India, Pakistan and Sri Lanka) and South East Asian countries (comprising of Japan, Malaysia, Philippine, Singapore and Thailand), the population attributable risk (PAR) for smoking was 37.4% and 36% respectively and is a good starting point for prevention.

   Integrating tobacco control in health system framework Top

A large percentage of NCDs are preventable through the reduction of their four main behavioural risk factors: Tobacco use, physical inactivity, harmful use of alcohol and unhealthy diet. [1] These risk factors are interlinked and operate synergistically. So, comprehensive population services focusing on major risk factors is required instead of standalone vertical tobacco control programmes. Similarly, integrated risk factor surveillance by using WHO STEPS approach may be a better option than single risk factor surveillance as is being done presently. Although member states have specific requirements for WHO FCTC implementation, it should be seen as an opportunity for integration of tobacco control to become an integral part of population and individual services under the health system framework in national policies and health programmes. Recently, the Lancet NCD Action Group and the NCD Alliance proposed five overarching priority actions for the response to NCD crisis- leadership, prevention, treatment, international cooperation, and monitoring and accountability-and the delivery of five priority interventions-tobacco control, salt reduction, improved diets and physical activity, reduction in hazardous intake of alcohol, and essential drugs and technologies. [16] The priority interventions were chosen for their health effects, cost effectiveness, low cost of implementation, and political and financial feasibility. [16] All such proposal makes a strong case for integrated comprehensive population services with multisectoral action. Tobacco taxes have been used not only as price-linked mechanisms for discouraging tobacco use, but also as a means of raising resources to fund health promotion and tobacco control programmes. Victoria (in Australia), California (in USA), Thailand, Nepal and India are among the countries that have supported public health programmes through 'sin tax.' [22] Thailand Health Promotion Foundation is generating sufficient funds for health promotion by having 2% cess on alcohol and tobacco which has the potential for replication in other member countries. The World Bank reviewed the evidence on the effectiveness of tobacco taxation in a 1999 report, and concluded that a 10% increase in the prices of tobacco products would reduce their use by about 4% in developed countries and by about 8% in developing countries. [23] Even lower rates of tax increase have produced beneficial effects. Regulatory measures should be supplemented by behavior change communication among target groups. Providing information to adults about tobacco dependence and health impact of tobacco can reduce consumption and is another best buy. [1] Therefore, comprehensive NCD prevention strategies should blend together two types of approaches of public health interventions aimed at reducing population level of risk factors including tobacco and medical interventions targeted specifically at high risk individuals.

   Conclusions and way forward Top

Tobacco smoking and smokeless tobacco use is widely prevalent in all countries and is contributing substantially to the burden of NCDs in SEAR countries. Tobacco control and WHO FCTC implementation by Member States should be accelerated and monitored in order reduce the rising burden of NCDs and sustain development in SEAR countries. Integrating tobacco control in broader population services appears to be a better strategy as compared to vertical tobacco control programme in SEAR countries.

   References Top

1.World Health Organization. The Global Status Report on Non Communicable Diseases. Geneva, 2010.  Back to cited text no. 1
2.Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. Mortality from smoking in Developed Countries 1950-2000. Indirect estimates from National Vital Statistics. Oxford: Oxford University Press; 1994.   Back to cited text no. 2
3.Parish S, Collins R, Peto R, Youngman L, Barton J, Jayne K, et al. Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14000 cases and 32000 controls in the United Kingdom. Br M J 1995;311:471-7.  Back to cited text no. 3
4.Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 1985;313:1511-4.   Back to cited text no. 4
5.Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: An evaluation of the evidence. Br Med J 1997;315:973-80.   Back to cited text no. 5
6.Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D'Souza GA, Gupta D, et al. A multicentric study on Epidemiology of chronic Obstructive Pulmonary Disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian Chest Dis Allied Sci 2006;48:23-9.   Back to cited text no. 6
7.Gupta D, Aggarwal AN, Chaudhry K, Chhabra Sk, D'Souza GA, Jindal SK, et al. Household environmental tobacco smoke exposure, Respiratory symptoms and asthma in nonsmoker adults: A multicentric population study from India. Indian Chest Dis Allied Sci 2006;48:31-6.  Back to cited text no. 7
8.WHO. Profile of Implementation of WHO Framework Convention on Tobacco Control in the South East Asia Region. New Delhi: World Health Organization, South East Asia Regional office; 2011.  Back to cited text no. 8
9.NCD Alliance. Briefing paper: Non-communicable Diseases, Tobacco control and the FCTC. 2011.  Back to cited text no. 9
10.World Health Organization. Systematic review of the link between tobacco and poverty, Geneva, 2011.  Back to cited text no. 10
11.World Health Organization. Regional Office for South-East Asia. Impact of tobacco related illness in Bangladesh. New Delhi, India, 2007.  Back to cited text no. 11
12.Doll R, Hill AB. The mortality of doctors in relation to their smoking habits. A preliminary report. BMJ 1954;228:1451-5.  Back to cited text no. 12
13.Doll R, Hill AB. Lung cancer and other causes of death in relation to smoking. A second report on mortality of British doctors. BMJ 1956;227:1011-6.  Back to cited text no. 13
14.NCD Alliance. Tobacco: A major risk factor for non communicable diseases. Putting non communicable diseases on global agenda. 2011.  Back to cited text no. 14
15.Jha P, Jacob B, Gajalakshmi V, Gupta PC, Dhingra N, Kumar R, et al. A nationally representative case control study of smoking and deaths in India. N Eng J Med 2008;358;1137-47.  Back to cited text no. 15
16.Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P. Priority action for the non communicable disease crisis. Lancet 2011.  Back to cited text no. 16
17.Asaria P, Chisholm D, Mather C, Ezatti M, Beaglehole R. Chronic disease prevention: Health effects and financial cost of strategies to reduce salt intake and control tobacco use. Lancet 2007;70:2044-53.  Back to cited text no. 17
18.Lightwood JM, Glantz SA. Short term economic and health benefit of smoking cessation: Myocardial infarction and stroke. Circulation 1997;96:1089-96.  Back to cited text no. 18
19.World Health Organization. WHO Report on the global tobacco epidemic, 2009. Geneva, 2009.  Back to cited text no. 19
20.Thakur JS. Chandigarh: The first smoke-free city in India (Editorial). Indian J Community Med 2007;32:169-70.  Back to cited text no. 20
  Medknow Journal  
21.Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364:937-52.  Back to cited text no. 21
22.World Health Organization. Regional Office for South-East Asia. Risk factors for Chronic Non Communicable diseases. Capacity Strengthening for Prevention and Control of Non communicable Diseases in South-East Asia Region. New Delhi, 2011.  Back to cited text no. 22
23.World Bank. Curbing the epidemic: Governments and the economics of tobacco control. Washington DC, 1999.  Back to cited text no. 23


  [Table 1], [Table 2], [Table 3], [Table 4]

This article has been cited by
1 Strategies to tackle non-communicable diseases in Afghanistan: A scoping review
Narges Neyazi, Ali Mohammad Mosadeghrad, Mahnaz Afshari, Parvaneh Isfahani, Najibullah Safi
Frontiers in Public Health. 2023; 11
[Pubmed] | [DOI]
2 Exposure to Electronic Media, Smoking and Alcohol Drinking Among Guyanese Adults
Liming Shao, Ting Zhang, Yanyan Chen, Bishwajit Ghose, Lu Ji
Frontiers in Public Health. 2022; 10
[Pubmed] | [DOI]
3 Prevalence of non-communicable diseases and its association with tobacco smoking cessation intention among current smokers in Shanghai, China
Ruiping Wang*, Yan Qiang*, Xiangjin Gao*, Qiong Yang, Bin Li
Tobacco Induced Diseases. 2022; 20(November): 1
[Pubmed] | [DOI]
4 Spatial Distribution and Factors Associated With Risky Health Behavior Among Adult Males Aged 15–59 Years in Ethiopia: Generalized Structural Equation Modeling
Sewnet Adem Kebede, Adisu Birhanu Weldesenbet, Biruk Shalmeno Tusa
Frontiers in Psychiatry. 2022; 13
[Pubmed] | [DOI]
5 Perceived Risk of Tobacco Use in COVID-19 Disease Causation and Severity among Healthcare Professionals: A Pan India Online Survey
Bijaya Nanda Naik, Chandramani Singh, Bijit Biswas, Sanjay Pandey, Santosh Kumar Nirala, Neha Chaudhary
National Journal of Community Medicine. 2022; 12(06): 140
[Pubmed] | [DOI]
6 Smokeless tobacco use and public health nutrition: a global systematic review
Shikha Saxena, Prashant Kumar Singh, Lucky Singh, Shekhar Kashyap, Shalini Singh
Public Health Nutrition. 2022; : 1
[Pubmed] | [DOI]
7 Nicotine dependence and quitting stages of smokers in Nepal: A community based cross-sectional study
Janaki Kumari Timilsina, Bimala Bhatta, Amrit Devkota, Abraham Salinas-Miranda
PLOS ONE. 2022; 17(4): e0266661
[Pubmed] | [DOI]
8 Cigarette smoking and associated factors among men in five South Asian countries: A pooled analysis of nationally representative surveys
Md Shariful Islam, Mamunur Rashid, Monaemul Islam Sizear, Raafat Hassan, Mahbubur Rahman, Sarker Masud Parvez, Shuvon Chandra Hore, Rehnuma Haque, Farjana Jahan, Supta Chowdhury, Tarique Mohammad Nurul Huda, K. M. Saif-Ur-Rahman, Arifuzzaman Khan, Rajesh Raushan
PLOS ONE. 2022; 17(11): e0277758
[Pubmed] | [DOI]
9 The discrepancy between Clove and Non-Clove Cigarette Smoke-Promoted Candida albicans Biofilm Formation with precoating RNA-aptamer
Boy Muchlis Bachtiar,Basri A. Gani,Astri Deviana,Nastiti Rilo Utami,Anissa Dien Andriyani,Endang Winiati Bachtiar
F1000Research. 2021; 10: 372
[Pubmed] | [DOI]
10 The Discrepancy between Clove and Non-Clove Cigarette Smoke-Promoted Candida albicans Biofilm Formation with Precoating RNA-aptamer
Boy Muchlis Bachtiar,Basri A. Gani,Astri Deviana,Nastiti Rilo Utami,Anissa Dien Andriyani,Endang Winiati Bachtiar
F1000Research. 2021; 10: 372
[Pubmed] | [DOI]
11 The Discrepancy between Clove and Non-Clove Cigarette Smoke-Promoted Candida albicans Biofilm Formation with Precoating RNA-aptamer
Boy Muchlis Bachtiar,Basri A. Gani,Astri Deviana,Nastiti Rilo Utami,Anissa Dien Andriyani,Endang Winiati Bachtiar
F1000Research. 2021; 10: 372
[Pubmed] | [DOI]
12 Burden of increased blood glucose due to modifiable risk factors among men in India
Rajeshwari A. Biradar,Dharmendra P. Singh,Jang Bahadur Prasad
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021; 15(3): 725
[Pubmed] | [DOI]
13 Risk Factors of Non-Communicable Diseases in a Frontier, Outermost, and Least Developed (3T) Archipelagic Region of Indonesia: a Community Study
Tiara Putri Leksono, Auliana Ratri Prabandari Hidayat, Fitrawan Silvano, Lutfan Lazuardi, Gunadi, T. Yamada, A.A.C. Pramana, Y. Ophinni, A. Gusnanto, W.A. Kusuma, J. Yunus, Afiahayati, R. Dharmastiti, T.R. Nuringtyas, P. Indrasetiawan, F. Hafidz As Shidieq
BIO Web of Conferences. 2021; 41: 03003
[Pubmed] | [DOI]
14 Assessment of nicotine dependence among tobacco users visiting outreach programs in Dharan, Nepal: a cross-sectional study
Krishna Subedi,Ashish Shrestha,Tarakant Bhagat
BMC Public Health. 2021; 21(1)
[Pubmed] | [DOI]
15 Perceived Change in Tobacco Use and Its Associated Factors among Older Adults Residing in Rohingya Refugee Camps during the COVID-19 Pandemic in Bangladesh
Sabuj Kanti Mistry, ARM Mehrab Ali, Uday Narayan Yadav, Md. Nazmul Huda, Saruna Ghimire, Md. Ashfikur Rahman, Sompa Reza, Rumana Huque, Muhammad Aziz Rahman
International Journal of Environmental Research and Public Health. 2021; 18(23): 12349
[Pubmed] | [DOI]
16 Tobacco Smoking, Secondhand Smoke Exposure and Cessation Perceptions by Dental Students in Al Madinah, a Conservative Saudi Society
Yosra Ayed, Shadia A Elsayed, Osama Abu-Hammad, Abdulaziz Turki, Mawadh Saleh, Moataz Karbouji, Ranad Alsaedi, Ismail Laher, Nebras Althagafi, Najla Dar-Odeh
Pesquisa Brasileira em Odontopediatria e Clínica Integrada. 2021; 21
[Pubmed] | [DOI]

Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease Among Agriculturists in a Rural Community, Central Thailand

Peranut Kitjakrancharoensin,Kittipong Yasan,Kwanjira Hongyantarachai,Kanoot Ratanachokthorani,Jutinun Thammasarn,Dantham Kuwuttiwai,Thunpimol Ekanaprach,Rawisut Jittakarm,Rungroj Nuntapravechpun,Sirasih Hotarapavanon,Spain Kulrattanarak,Sarisa Tongkaew,Sirivimon Deemeechai,Mathirut Mungthin,Ram Rangsin,Virissorn Wongsrichanalai,Boonsub Sakboonyarat
International Journal of Chronic Obstructive Pulmonary Disease. 2020; Volume 15: 2189
[Pubmed] | [DOI]
18 Prevalence of Common Mental Disorders in South Asia: A Systematic Review and Meta-Regression Analysis
Sadiq Naveed,Ahmed Waqas,Amna Mohyud Din Chaudhary,Sham Kumar,Noureen Abbas,Rizwan Amin,Nida Jamil,Sidra Saleem
Frontiers in Psychiatry. 2020; 11
[Pubmed] | [DOI]
19 Cross sectional study on Kashmiri tribal population: Their demo-economic status and behavioural risk factors
MohdAshraf Ganie,Arif Habib,SheikhAbid Ali,Aafia Rashid,Rabiya Rashid,Anjum Fazili
Journal of Family Medicine and Primary Care. 2020; 9(9): 4929
[Pubmed] | [DOI]
20 One size doesn’t fit all: contouring and addressing social vitals in reversing tobacco epidemic in Punjab, India
Garima Bhatt,Sonu Goel,Gagandeep Shergill
BMJ Case Reports. 2020; 13(3): e231890
[Pubmed] | [DOI]
21 Factors associated with tobacco use among Nepalese men aged 15–49 years: Data from Nepal demographic and Health Survey 2016
Rajat Das Gupta,Mahmuda Jahan,Mehedi Hasan,Ipsita Sutradhar,Ibrahim Hossain Sajal,Shams Shabab Haider,Hemraj Joshi,Mohammad Rifat Haider,Malabika Sarker
Clinical Epidemiology and Global Health. 2020; 8(3): 748
[Pubmed] | [DOI]
22 Awareness about behavioral risk factors of noncommunicable diseases and practices related to healthy lifestyle among class IV female employees in a tertiary care hospital of Eastern India
Saswatika Beura,Lipilekha Patnaik,Sumitra Pattanaik,Trilochan Sahu
Journal of Datta Meghe Institute of Medical Sciences University. 2019; 14(3): 244
[Pubmed] | [DOI]
23 The tobacco trade and trail in Karnataka
Punith Shetty,Roomani Srivastav,Arpan Debnath,R Murali,A Shamala
Indian Journal of Cancer. 2018; 55(4): 394
[Pubmed] | [DOI]
24 Compliance of Cigarettes and Other Tobacco Products Act among Tobacco Vendors, Educational Institutions, and Public Places in Bengaluru City
Naveen Chandrahas Khargekar,Arpan Debnath,Nitin Ravindra Khargekar,Punith Shetty,Vandana Khargekar
Indian Journal of Medical and Paediatric Oncology. 2018; 39(04): 463
[Pubmed] | [DOI]
25 Genomic and Bioinformatics Approaches for Analysis of Genes Associated With Cancer Risks Following Exposure to Tobacco Smoking
Mohammed A. I. Al-Obaide,Buthainah A. Ibrahim,Saif Al-Humaish,Abdel-Salam G. Abdel-Salam
Frontiers in Public Health. 2018; 6
[Pubmed] | [DOI]
26 Socio-demographic characteristics and tobacco use among the adults in urban slums of Dhaka, Bangladesh
Nusrat Nausheen Khandker,Tuhin Biswas,Abdullah Nurus Salam Khan,Enamul Hasib,Lal B Rawal
Tobacco Induced Diseases. 2017; 15(1)
[Pubmed] | [DOI]
27 Urban-rural differences in the prevalence of non-communicable diseases risk factors among 25–74 years old citizens in Yangon Region, Myanmar: a cross sectional study
Aung Soe Htet,Marius B. Bjertness,Lhamo Y. Sherpa,Marte Karoline Kjøllesdal,Win Myint Oo,Haakon E. Meyer,Hein Stigum,Espen Bjertness
BMC Public Health. 2016; 16(1)
[Pubmed] | [DOI]
28 Estimation of the Disease Burden Attributable to 11 Risk Factors in Hubei Province, China: A Comparative Risk Assessment
Fangfang Cui,Lan Zhang,Chuanhua Yu,Songbo Hu,Yunquan Zhang
International Journal of Environmental Research and Public Health. 2016; 13(10): 944
[Pubmed] | [DOI]
29 A retrospective analysis of the association between tobacco smoking and deaths from respiratory and cardiovascular diseases in the Kassena-Nankana districts of Northern Ghana
Philip Ayizem Dalinjong,Paul Welaga,Daniel K Azongo,Samuel Chatio,Dominic Anaseba,Felix Kondayire,James Akazili,Cornelius Debpuur,Abraham Rexford Oduro
Tobacco Induced Diseases. 2015; 13(1)
[Pubmed] | [DOI]
Yasmeen Jan,Rafiq Mir,Najami Arshid,Ashfaq Bhat,Beenish Mushtaq,Javid Ahamd
Journal of Evolution of Medical and Dental Sciences. 2015; 4(02): 242
[Pubmed] | [DOI]
31 Smoking and smokeless tobacco use in nine South and Southeast Asian countries: prevalence estimates and social determinants from Demographic and Health Surveys
Chandrashekhar T Sreeramareddy,Pranil Pradhan,Imtiyaz Mir,Shwe Sin
Population Health Metrics. 2014; 12(1): 22
[Pubmed] | [DOI]
32 Stroke in South Asian countries
Mohammad Wasay,Ismail A. Khatri,Subhash Kaul
Nature Reviews Neurology. 2014; 10(3): 135
[Pubmed] | [DOI]
33 Smokeless Tobacco Use: A Risk Factor for Hyperhomocysteinemia in a Pakistani Population
Mohammad Perwaiz Iqbal,Mohsin Yakub,Utpal Sen
PLoS ONE. 2013; 8(12): e83826
[Pubmed] | [DOI]
34 Socioeconomic Inequality in the Prevalence of Smoking and Smokeless Tobacco use in India
Jarnail Singh Thakur,Shankar Prinja,Nidhi Bhatnagar,Saroj Rana,Dhirendra Narain Sinha,Poonam Khetarpal Singh
Asian Pacific Journal of Cancer Prevention. 2013; 14(11): 6965
[Pubmed] | [DOI]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
    Prevalence of to...
    Burden of NCDs a...
    Tobacco as a dev...
    Evidence of asso...
    Best buys for Pr...
    Integrating toba...
    Conclusions and ...
    Article Tables

 Article Access Statistics
    PDF Downloaded1789    
    Comments [Add]    
    Cited by others 34    

Recommend this journal